Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease - Wikidata - wikimedia - TriplyDB

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease

http://www.wikidata.org/entity/Q34939232

about

Dietary interventions for mineral and bone disorder in people with chronic kidney disease Fibroblast growth factor 23 Phosphate binders in chronic kidney disease: a systematic review of recent data.Calcium Balance in Chronic Kidney Disease.The use of fibroblast growth factor 23 testing in patients with kidney disease.Calcium balance and negative impact of calcium load in peritoneal dialysis patients.The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease.Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Serum vitamin D and parathyroid hormone profiles in patients with various stages of renal disease The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease.Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure.Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.The demise of calcium-based phosphate binders-is this appropriate for children?Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study.Treatment of phosphate retention: The earlier the better?Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.Nutrition in Cardioskeletal Health.Phosphate Toxicity in CKD: The Killer among Us Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.Delayed progression to dialysis with early and intensive management of predialysis chronic kidney disease: a case-based approach.Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia.A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.Optimal use of phosphate binders in chronic kidney disease.Are calcium-based phosphate binders ever preferable in dialysis patients?Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.Calcium supplementation in chronic kidney disease.The role of bone in CKD-mediated mineral and vascular disease.The challenge of controlling phosphorus in chronic kidney disease.Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.Advances in pharmacotherapy for hyperphosphatemia in renal disease.Pro: Should phosphate binders be used in chronic kidney disease stage 3-4?Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.Dietary Phosphorus Intake and the Kidney.A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

P2860

Q24187142-862C542E-9944-4577-8E13-BB38CD57EAD3 Q26829294-851B549E-3FB0-4C6B-A95C-FA106638E8EE Q31039292-BA61F0C2-6BBE-4BD5-90EC-B287ED004DED Q33720411-A21A0E51-BA1D-41F4-8274-DB149CE39196 Q33835743-FD68B1F7-8396-4946-A055-0C6C04F9F2EA Q33837633-004020EE-1A99-422C-9CB5-158FDEFFACEF Q34337575-F7DC3334-FE03-4EF2-A590-EA479ACACDF7 Q34505136-C04BF1F1-CBD9-4889-A139-CB1F1BC979CB Q35067500-002E2EEE-2053-4889-903E-DB7BACA8501C Q35160399-B828BD92-B06B-46C2-BB8B-EA9955FA7234 Q35218508-0E56EBFB-88A8-49EB-8EFA-C666FF348869 Q35841012-5F6C913F-EEDC-44F9-A804-735DFCF3DC8B Q36104887-2148CC39-56F9-4D99-B046-7C16AB9C7212 Q36214854-FC1DB979-7076-426F-9486-564B30753C5D Q36361143-087905F5-CF43-4AC5-93A9-4AFF09B12232 Q36466010-0FED0E96-1735-4E6B-9592-913B7EF226B5 Q36746618-90A60A19-08BB-4281-AC79-5E081324525C Q36890341-90A97890-8A0D-48DB-BE2C-7C723FE6DE71 Q36965142-60CB048E-6264-44A9-9ED6-C93A70AB0783 Q37204047-25CD68A2-2F52-47A2-844A-A4CD57F9BDEE Q37256525-D032434B-1A83-444E-BF9E-D8C4FD40BFB6 Q37333243-F1D98FE3-A7A1-452E-8FC8-DD7C52F5A6C3 Q37416887-A8099380-1F38-4ED8-9050-0A06382AF7F0 Q37613856-9B92592F-0732-4131-B92E-6CD2E745A710 Q37614180-987B206D-DEC5-487F-8796-31936D5D7A68 Q37734160-ED7B56E3-47CC-472B-AD51-E5FAC870915C Q38161580-71A582BC-B17F-4F95-8914-4E5CF2BC62E3 Q38195297-41031EBB-865A-4C97-B98A-8A1BA3FD87F8 Q38202179-0069CF3E-532E-4D3C-ACAD-314D4AF513D2 Q38229798-8F950C77-7F8A-4190-9213-A52F3B965D01 Q38240989-B0458072-8137-4770-80B3-7B33967B4197 Q38244314-29BEEC01-6D09-49D1-85E3-F13E5F310DCF Q38377286-426F878B-0897-4550-9062-8F8D9F717097 Q38572880-7DCD2861-3505-43E4-9920-AB6B17A6A7E2 Q38584122-4C162591-CB67-4C58-B85F-C301C180BBD8 Q38587575-479EF077-C588-41D7-85E2-5B64B40A7D3B Q38673170-AA4EAC91-073D-4131-8977-6BCA07C8C12D Q38685859-2F737E26-7B8E-4358-BAED-FB2EF43E96F1 Q38725971-DDE8DD58-E64E-4595-8434-736DAFEB29C5 Q38741675-5545832C-51AE-450D-9E2A-B02004AF36D1

P2860

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease

http://www.wikidata.org/entity/Q34939232

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@ast

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@en

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@nl

type

label

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@ast

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@en

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@nl

prefLabel

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@ast

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@en

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@nl

P1433

Q34939232-5CE1F882-D0EF-4452-BD06-8E3E55305F11

P1476

Q34939232-6E438D54-FC69-4A65-8F93-4B5EA7CBC2DA

P2093

Q34939232-0278A1A4-A325-4E33-8DE3-87036DCE8952

Q34939232-03EAE60D-DEE8-4B1F-AB26-18B489E4B319

Q34939232-525F0E86-6F5F-4020-A5F6-2DDF55FAB833

Q34939232-5CFC75B5-2DAA-4D0A-87E0-7ABE2C091866

Q34939232-C2C87811-69CD-4DEF-B8D2-1F00C94C6244

Q34939232-F48CD7BB-519A-40EC-BD24-8A810B0645CB

Q34939232-FE7C1915-A752-4AB4-B536-8D16AFA550A7

P2860

Q34939232-10F89443-AB91-4D89-80C0-240173FD3DE7

Q34939232-1F947F11-E165-459E-BC1E-E1BE659F4287

Q34939232-20FE0943-BE71-420C-8493-AD551D098343

Q34939232-26A598D3-ACDB-4526-B56E-4323F61460E5

Q34939232-2B2D8EB3-6C20-4198-A323-A9FFEA5DD253

Q34939232-3C86BA0F-EFCD-43E2-B242-8C9A9B858FD9

Q34939232-48A22AFB-D2B8-4B28-A3E7-0135261C7CD3

Q34939232-6BE6A7B4-2ED8-48C9-A738-75B1B6511643

Q34939232-6FD8EC56-BB0B-4676-A6C5-028AAD9A8DE8

Q34939232-7A622BC0-20CB-4939-BE71-F0919146B1CA

P2888

Q34939232-5202B14C-F903-454C-8CD2-FE9E169907EC

P304

Q34939232-886D1D1A-E010-4320-BA44-F4FD67B3712D

P31

Q34939232-3C73D8CA-D8F0-4BBF-8494-9DB5913D0644

P356

Q34939232-F187FE3F-0A7E-4343-A127-BB4945760786

P407

Q34939232-C653756E-E50F-4FDD-9905-53CAD6E94F3D

P433

Q34939232-12413D99-5DBF-4A6A-9D7F-BFA0F7B51086

P478

Q34939232-F3274FEF-F1B8-4F7E-81FA-1869522383CA

P577

Q34939232-B3B1333F-D049-40CE-A9AE-D3E2C7418E31

P5875

Q34939232-6077D6EA-786A-46B8-A4D4-9898A509605E

P6179

Q34939232-D022A510-7111-441E-B842-212D9E905D02

P698

Q34939232-A72F8962-59F9-497B-9F7E-5670A87EB27F

P932

Q34939232-BB3FADE7-B4CB-4666-821A-F6F28FC40019

P356

P1433

Kidney International

P1476

Oral calcium carbonate affects ...... age 3-4 chronic kidney disease

@en

P2093

Berdine R Martin

http://www.w3.org/2001/XMLSchema#string

Connie M Weaver

http://www.w3.org/2001/XMLSchema#string

George P McCabe

http://www.w3.org/2001/XMLSchema#string

Kathleen M Hill

http://www.w3.org/2001/XMLSchema#string

Meryl E Wastney

http://www.w3.org/2001/XMLSchema#string

Munro Peacock

http://www.w3.org/2001/XMLSchema#string

Sharon M Moe

http://www.w3.org/2001/XMLSchema#string

P2860

A Biometric Study of Human Basal Metabolism

Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets.

CKD-mineral and bone disorder: core curriculum 2011.

Intestinal absorption of calcium and the effect of renal insufficiency.

Changing phosphorus content of the U.S. diet: potential for adverse effects on bone.

P2888

P304

959-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2012.403

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233958146

http://www.w3.org/2001/XMLSchema#string

P6179

1041866258

http://www.w3.org/2001/XMLSchema#string

P698

23254903

http://www.w3.org/2001/XMLSchema#string

P932

4292921

http://www.w3.org/2001/XMLSchema#string